<?xml version="1.0" encoding="UTF-8"?>
<p>These scaffolds were extended with Î±2,6-SiaLacNAc linked to lactose. The largest of the compounds were larger (more atoms in the spacers between sialic acid units; see 
 <ext-link ext-link-type="uri" xlink:href="http://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.9b00303/suppl_file/jm9b00303_si_001.pdf" xmlns:xlink="http://www.w3.org/1999/xlink">Supporting Information</ext-link>) than a biantennary Sia(LacNAc)
 <sub>3</sub> linked to a trimannose core, known for chelation.
 <sup>
  <xref ref-type="bibr" rid="ref16">16</xref>
 </sup> The constructs were evaluated as inhibitors in a viral binding assay and were shown to be significantly stronger inhibitors than their monovalent counterparts, and they were hardly affected by neuraminidases. Finally, they were also shown to inhibit IAV infection.
</p>
